Who
Lance A. Berry
EVP, COO, CFO & Treasurer
Company insider
Files Form 4 as: EVP, COO, CFO & Treasurer, Artivion; Director, Treace Medical Concepts; Director, Vapotherm; EVP, Chief Fin & Op Officer, Wright Medical Group; Sr. VP & CFO, Wright Medical Group.
In numbers
- Trades disclosed
- 186
- Buys
- 2
- Sells
- 49
- Bought
- $150K
- Sold
- $14.6M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 11 Dec 2009
- Last trade
- 14 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 17 Aug 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $20K715 at $28.55 | filing |
| 14 Aug 2026filed 17 Aug 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $20K715 at $28.55 | filing |
| 19 May 2026filed 19 May 2026 | TMCI Treace Medical ConceptsMedical Devices | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 19 May 2026filed 19 May 2026 | TMCI Treace Medical ConceptsMedical Devices | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Mar 2026filed 4 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $239K6,316 at $37.78 | filing |
| 3 Mar 2026filed 4 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $239K6,316 at $37.78 | filing |
| 2 Mar 2026filed 4 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —40,874 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —40,874 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $197K5,178 at $38.02 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $197K5,178 at $38.02 | filing |
| 24 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $160K4,485 at $35.69 | filing |
| 24 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —37,482 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $160K4,485 at $35.69 | filing |
| 24 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —37,482 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $187K4,981 at $37.59 | filing |
| 23 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $187K4,981 at $37.59 | filing |
| 20 May 2025filed 21 May 2025 | TMCI Treace Medical ConceptsMedical Devices | SEC FORM 4 Code A | —23,917 at $0.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —48,100 at $0.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $122K4,909 at $24.80 | filing |
| 28 Feb 2025filed 4 Mar 2025 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —34,435 at $0.00 | filing |
News
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial ResultsAORT · prnewswire.com · 22 Oct 2026
0 headlines in the last 90 days name Lance A. Berry; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.